Private Market View

BioBeaute

Tokyo, Japan · Founded 2024 · Privately Held (backing)

Last price · $/share
Implied valuation
Total raised
Last round

Key facts

  • Notable investors include Global Brain, AIS Capital, EPS Soken Trading.
  • Status: Privately Held (backing).
Free account
See the evidence behind this price
  • ·The complete investor list — 3 names
  • ·Watchlist + deal alerts for BioBeaute
  • ·The full record, as it builds
Create free account
No card required

Funding rounds

No rounds on record

No funding rounds for BioBeaute are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

About BioBeaute

Operator of a cosmetics and healthcare product firm intended to bridge the gap between academic research and industry application. The company offers advanced research-driven technologies, including innovative active ingredients and formulation techniques, enabling cosmetic brands and beauty product manufacturers in Japan and Asia to access cutting-edge developments and enhance their product offerings.

Sector
Consumer Products and Services (B2C)
HQ
Tokyo, Japan
Founded
2024
Ownership
Privately Held (backing)
PA Mark — not yet priced

BioBeaute doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.

Recorded secondary trades

No prints on record

No secondary trades in BioBeaute shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.

Pro members can request priority coverage with a 48-hour turnaround.

Institutional fund marks

No fund marks yet

No SEC-registered fund has reported a fair-value mark on BioBeaute in its N-PORT filings yet. We sweep new filings monthly.

Pro members can request priority coverage with a 48-hour turnaround.